Synvisc ratings & reviews

Hylan Polmers (Hylan A/Hylan B) (Avain)
Company: Sanofi US
Brand: Synvisc
Drug class: Musculo-Skeletal System
+2 more
Musculo-Skeletal System, Other Agents For Disorders of The Musculo-skeletal System, All Other Musculoskeletal Agents

Sermo AI Overview

  • Synvisc is generally well tolerated and can be a suitable alternative for patients, especially those unable to use corticosteroid injections for osteoarthritis. However, its accessibility is often hindered by high costs and variable insurance coverage.
  • While some healthcare professionals find Synvisc effective for osteoarthritis, it's noted that its benefits may not greatly exceed those of corticosteroids for all patients, indicating variability in therapeutic outcomes.
Based on insights from Sermo’s triple verified physicians

Description

HYLAN G-F 20 (HI lan G F 20) treats arthritis of the knee. It works by acting like a lubricant and cushion in the joint. This helps the joint move easily, which reduces pain.

Dosage & Administration

How should I use this medication?

This medication is injected into the knee joint. It is given by your care team in a hospital or clinic setting. Talk to your care team about the use of this medication in children. Special care may be needed.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once. NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

Keep appointments for follow-up doses. It is important not to miss your dose. Call your care team if you are unable to keep an appointment.

Where should I keep my medication?

This medication is given in a hospital or clinic. It will not be stored at home.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

Side Effects

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible: -Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat -Painful swelling, warmth, or redness of the skin, blisters or sores -Severe pain, redness, warmth, or swelling in joint where injected Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome): -Joint pain -Pain, redness, or irritation at injection site -Swelling in the joint where injected

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings & Precautions

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions: -Severe knee inflammation -Skin conditions or sensitivity -Skin or joint infection -Venous stasis -An unusual or allergic reaction to hylan G-F 20, hyaluronan (sodium hyaluronate), other medications, foods, dyes, or preservatives -Pregnant or trying to get pregnant -Breast-feeding

What may interact with this medication?

Do not take this medication with any of the following: -Certain skin disinfectants, such as benzalkonium chloride -Other injections for the joint, such as steroids or anesthetics

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Visit your care team for regular checks on your progress. Tell your care team if your symptoms do not start to get better or if they get worse. Your condition will be monitored carefully while you are receiving this medication. Most people get pain relief for up to 6 months after treatment. Avoid strenuous activities (high-impact sports, jogging) or major weight-bearing activities for 48 hours after the injection.

Source: This information is sourced from Elsevier Inc.

Disclaimer

The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.

Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.

Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.

Terms of use

  1. Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool). 

  2. Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc.  Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”).  Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.

Welcome to Sermo's Drug Ratings

Previously only for members, Sermo Drug Ratings are now openly available to all healthcare providers, patients, and industry professionals to support better healthcare decisions.

Clinical expertise
Insights based on real prescribing experience from triple-verified practicing physicians only
Detailed insights
Ratings on key attributes including efficacy, safety, tolerability, accessibility, and adherence
Unbiased reviews
Independent, physician-only reviews, free from pharmaceutical industry influence